Intravenously injected CDP-choline increases blood pressure and reverses hypotension in haemorrhagic shock: Effect is mediated by central cholinergic activation

European Journal of Pharmacology

Volumn 468, Issue 2, 2003, Pages 129-139

  Savci, Vahide ^a   Goktalay, Gokhan ^a   Cansev, Mehmet ^a   Cavun, Sinan ^a   Yilmaz, M Sertac ^a   Ulus, Ismail H ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Catecholamine; CDP choline; Choline; Cytidine; Haemorrhagic shock; Vasopressin

Indexed keywords

ACETYLCHOLINE; ARGIPRESSIN[1 (3,3 CYCLOPENTAMETHYLENE 3 MERCAPTOPROPIONIC ACID) 2 (O METHYLTYROSINE)]; ATROPINE; CATECHOLAMINE; CHOLINE; CITICOLINE; CYTIDINE; HEMICHOLINIUM 3; MECAMYLAMINE; NICOTINIC RECEPTOR; PRAZOSIN; RENIN; VASOPRESSIN; VASOPRESSIN ANTAGONIST; VASOPRESSIN V1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE REGULATION; BRAIN LEVEL; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RESPONSE; CATECHOLAMINE BLOOD LEVEL; CENTRAL NERVOUS SYSTEM; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DEATH; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HEMORRHAGIC HYPOTENSION; HEMORRHAGIC SHOCK; HYPOTHALAMUS; LATERAL BRAIN VENTRICLE; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; VASOPRESSIN BLOOD LEVEL;

EID: 0037720339     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01602-9     Document Type: Article

References (30)

1. Adibhatla R.M., Hatcher J.F., Dempsey R.J. Citicoline: neuroprotective mechanisms in cerebral ischemia. J. Neurochem. 80:2002;12-23.
2. Agut J., Font E., Sacristan A., Ortiz J.A. Dissimilar effects in acute toxicity studies of CDP-choline and choline. Arzneim.-Forsch. 33(7A):1983;1016-1018.
3. Amenta F., Parnetti L., Gallai V., Wallin A. Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches? Mech. Ageing Dev. 16:2001;2025-2040.
4. Arslan B.Y., Ulus I.H., Savci V., Kiran B.K. Effects of intracerebroventricularly injected choline on cardiovascular functions and sympathoadrenal activity. J. Cardiovasc. Pharmacol. 17:1991;814-821.
5. Buyukuysal R.L., Ulus I.H., Aydin S., Kiran B.K. 3,4-Diaminopyridine and choline increase in vivo acetylcholine release in rat striatum. Eur. J. Pharmacol. 281:1995;179-185.
6. Cacabelos R., Alvarez X.A., Franco-Maside A., Fernandez-Novoa L., Caamano J. Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multiinfarct dementia. Ann. N.Y. Acad. Sci. 16:1994;211-218.
7. Cacabelos R., Alvarez X.A., Fernandez-Novoa L., Lombardi V.R. A pharmacogenomic approach to Alzheimer's disease. Acta Neurol. Scand., Suppl. 176:2000;12-19.
8. Carlezon W.A. Jr., Pliakas A.M., Parow A.M., Detke M.J., Cohen B.M., Renshaw P.F. Antidepressant-like effects of cytidine in the forced swim test in rats. Biol. Psychiatry. 51:2002;882-889.
9. Cubells J.M., Hernando C. Clinical trial on the use of cytidine diphosphate choline in Parkinson's disease. Clin. Ther. 10:1988;664-671.
10. Dixon C.E., Ma X., Marion D.W. Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release. J. Neurotrauma. 14:1997;161-169.
11. D'Orlando K.J., Sandage B.W. Jr. Citicholine (CDP-choline): mechanism of action and effects in ischemic brain injury. Neurol. Res. 17:1995;264-281.
12. Grieb P., Rejdak R. Pharmacodynamics of citicoline relevant to the treatment of glaucoma. J. Neurosci. Res. 67:2002;143-148.
13. Gurun M.S., Savci V., Ulus I.H., Kiran B.K. Centrally administered choline increases plasma prolactin levels in conscious rats. Neurosci. Lett. 232:1997;79-82.
14. Lopez G.-Coviella I., Agut J., Wurtman R.J. Effect of cytidine (5′)-diphosphocholine (CDP-choline) on the total urinary excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG) by rats and humans. J. Neural Transm. 66:1986;129-134.
15. Lopez G.-Coviella I., Agut J., Von Borstel R., Wurtman R.J. Metabolism of cytidine (5′)-diphosphocholine (CDP-choline) following oral and intravenous administration to the human and the rat. Neurochem. Int. 11:1987;293-297.
16. Lopez G.-Coviella I., Agut J., Savci V., Ortiz J.A., Wurtman R.J. Evidence that 5′-cytidinediphosphocholine can affect brain composition by increasing choline and cytidine plasma levels. J. Neurochem. 65:1995;889-894.
17. Savci V., Ulus I.H. Cardiovascular effects of central choline during endotoxin shock in the rat. J. Cardiovasc. Pharmacol. 30:1997;667-675.
18. Savci V., Ulus I.H. Choline administration reverses hypotension in spinal cord transected rats: the involvement of vasopressin. Neurochem. Res. 23:1998;737-745.
19. Savci V., Gurun M.S., Ulus I.H., Kiran B.K. Intracerebroventricular injection of choline increases plasma oxytocin levels in conscious rats. Brain Res. 709:1996;97-102.
20. Savci V., Gurun M.S., Cavun S., Ulus I.H. Cardiovascular effects of centrally injected tetrahydroaminoacridine in conscious normotensive rats. Eur. J. Pharmacol. 346:1998;35-41.
21. Savci V., Cavun S., Gurun M.S., Ulus I.H. Reversal of haemorrhagic shock in rats by tetrahydroaminoacridine. Pharmacology. 62:2001;36-44.
22. Savci V., Cavun S., Goktalay G., Ulus I.H. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system. Naunyn-Schmiedeberg's Arch. Pharmacol. 365:2002;388-398.
23. Scally M.C., Ulus I.H., Wurtman R.J. Choline administration to the rat increases urinary catecholamines. J. Neural Transm. 43:1978;102-112.
24. Toung T., Reilly P.M., Fuh K.C., Ferris R., Bulkley G.B. Mesenteric vasoconstriction in response to hemorrhagic shock. Shock. 13(4):2000;267-273.
25. Ulus I.H., Wurtman R.J., Mauron C., Blusztajn J.K. Choline increases acetylcholine release and protects against the stimulation induced decrease in phosphatide levels within membranes of rat corpus striatum. Brain Res. 484:1989;217-227.
26. Ulus I.H., Arslan B.Y., Savci V., Kiran B.K. Restoration of blood pressure by choline treatment in rats made hypotensive by haemorrhage. Br. J. Pharmacol. 116:1995;1911-1917.
27. Warach S., Pettigrew L.C., Dashe J.F., Pullicino P., Lefkowitz D.M., Sabounjan L., Harnett K., Schwiderski U., Gammans R. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 investigators. Ann. Neurol. 48:2000;713-722.
28. Weiss G.B. Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Sci. 56:1995;637-660.
29. Wurtman R.J. Neuronal death mechanisms in cerebral ischemia: laboratory at the clinic. Rev. Neurol. 29:1999;524-526.
30. Wurtman R.J., Regan M., Ulus I.H., Yu L. Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem. Pharmacol. 60:2000;989-992.